AbbVie (ticker: ABBV) financial results announcement
✅ Sales
Forecast of 11.936 billion dollars → result of 12.310 billion dollars (0.7% increase from the same period last year)
Forecast of 11.936 billion dollars → result of 12.310 billion dollars (0.7% increase from the same period last year)
✅ Earnings per share
Expected $2.26 → Result $2.31 (down 6.1% year on year)
Expected $2.26 → Result $2.31 (down 6.1% year on year)
✅ Guidance
Earnings per share were revised upward
Expected $11.1 → result 11.13-11.33
Earnings per share were revised upward
Expected $11.1 → result 11.13-11.33
AbbVie is a scheme where Humira's sales melt and Skillage and Lynvock support it. Humira's sales declined more than expected, and it fell after the settlement, but personally I think it got worse, so I'm looking forward to the future.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
